Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.11.4659

Significant Correlation between Salivary and Serum Ca 15-3 in Healthy Women and Breast Cancer Patients  

Laidi, Fatna (Oral Biomechanics and Biotechnology Research Unit, Faculty of Dental Medicine, Mohammed 5th Souissi University)
Bouziane, Amal (Department of Periodontology Faculty of Dental Medicine, Biostatistical, Clinical and Epidemiological Research Laboratory, Faculty of Medicine and Pharmacy, Mohammed 5th Souissi University)
Lakhdar, Amina (Department of Obstetrics and Gynecology, Ibn Sina University Hospital Rabat)
Khabouze, Samira (Department of Obstetrics and Gynecology, Ibn Sina University Hospital Rabat)
Amrani, Mariam (Pathology Department, National Institute of Oncology)
Rhrab, Brahim (Department of Obstetrics and Gynecology, Ibn Sina University Hospital Rabat)
Zaoui, Fatima (Oral Biomechanics and Biotechnology Research Unit, Faculty of Dental Medicine, Mohammed 5th Souissi University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.11, 2014 , pp. 4659-4662 More about this Journal
Abstract
The tumor marker CA 15-3 is one of the most import reliable for metastatic breast cancer monitoring. While it is generally assessed in serum of patients, blood sampling is an invasive method compared to saliva sampling which is simple and could be an alternative to blood according to many studies. The aim of this investigation was to assess the relationship between serum and salivary concentrations of the protein CA 15-3 in patients with breast cancer and healthy asymptomatic volunteers. A case-control study was conducted with 60 women: 29 breast cancer patients from the Maternity Hospital Souissi Rabat (Morocco) and 31 healthy asymptomatic women. The CA 15-3 concentrations in saliva and serum samples were assessed using an enzyme immune assay (EIA kits) and comparison between cases and controls was made by the Mann-Whitney test. The correlation between serum and saliva CA 15-3 concentration was tested using Pearson correlation. The comparison result of CA15-3 concentration in saliva and serum level in cases and controls was not statistically significant (p>0.05). However, the correlation between salivary and serum CA 15-3 concentration was positive and statistically significant (r=0.27, p=0.03). In conclusion, the positive correlation between salivary and serum expression found in our study suggests that saliva could be an alternative to blood sampling to help breast cancer monitoring.
Keywords
Breast cancer; tumor markers; CA 15-3; serum; saliva; diagnostic approaches;
Citations & Related Records
Times Cited By KSCI : 5  (Citation Analysis)
연도 인용수 순위
1 Agha-Hosseini F, Mirzaii-Dizgah I, Rahimi A (2009). Correlation of serum and salivary CA15-3 levels in patients with breast cancer. Medicina Oral S, 10, 521-4.
2 Atoum M, Nimer N, Abdeldayem S, et al (2012). Relationships among serum CA15-3 tumor marker, tnm staging, and estrogen and progesterone receptor expression in benign and malignant breast lesions. Asian Pac J Cancer Prev, 13, 857-60.   과학기술학회마을   DOI   ScienceOn
3 Colomer R, Ruibal A, Salvador L (1989). Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease. Cancer, 64, 1674-81.   DOI
4 Begum M, Karim S, Malik A, et al (2012). CA 15-3 (mucin-1) and physiological characteristics of breast cancer from Lahore, Pakistan. Asian Pac J Cancer Prev, 13, 5257-61.   과학기술학회마을   DOI
5 Bigler LR, Streckfus CF, Copeland L, et al (2002). The potential use of saliva to detect recurrence of disease in women with breast carcinoma. J Oral Pathol Med, 31, 421-31.   DOI
6 Clinton SR, Beason KL, Bryant S, et al (2003). A comparative study of four serological tumor markers for the detection of breast cancer. Biomed Sci Instrum, 39, 408-14.
7 Dilhuydy M-H (2009). Imagerie au service du depistage : l'exemple du depistage organise du cancer du sein. Bull Cancer, 96, 1071-86.
8 Frenette PS, Thirlwell MP, Trudeau M, et al (1994) The diagnostic value of CA 27-29, CA 15-3, mucin-like carcinoma antigen, carcinoembryonic antigen and CA 19-9 in breast and gastrointestinal malignancies. Tumour Biol, 15, 247-54.   DOI
9 Hofman L F (2001). Human Saliva as a Diagnostic Specimen. J Nutr, 131, 1621-5.
10 Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.   DOI
11 Lac G (1998). Interet et champs d'application des dosages salivaires. Science & Sports, 13, 55-63.   DOI
12 Mandel ID (1993). Salivary diagnosis: promises, promises. Ann N Y Acad Sci, 694, 1-10.   DOI
13 Maric P, Ozretic P, Levanat S, et al (2011). Tumor Markers in Breast Cancer-Evaluation of their Clinical Usefulness. Coll Antropol, 35, 241-7.
14 Navazesh M, Christensen CM (1982). A comparison of whole mouth resting and stimulated salivary measurement procedures. J Dent Res, 61, 1158-62.   DOI   ScienceOn
15 Navazesh M (1993). Methods for collecting saliva. Ann N Y Acad Sci, 694, 72-7.   DOI
16 Mcintyre R, Bigler L, Dellinger T, et al (1999). Oral contraceptive usage and the expression of CA 15-3 and c-erbB-2 in the saliva of healthy women. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 88, 687-90.   DOI
17 Moazzezy N, Farahany T-Z, Oloomi M, et al (2014). Relationship between preoperative serum CA15-3 and CEA levels and clinicopathological parameters in breast cancer. Asian Pac J Cancer Prev, 15, 1685-8.   과학기술학회마을   DOI
18 Nicolini A, Carpi A, Ferrari P, et al (2008). Immunotherapy prolongs the serum CEA-TPA-CA15.3 lead time at the metastatic progression in endocrine-dependent breast cancer patients: a retrospective longitudinal study. Cancer Lett, 263, 122-9.   DOI   ScienceOn
19 Porika M, Malotu N, Veldandi U-K, et al (2010). Evaluation of tumor markers in Southern Indian breast cancer patients. Asian Pac J Cancer Prev, 11, 157-9.
20 Ray A (2012). Adipokine leptin in obesity-related pathology of breast cancer. J Biosci, 37, 289-94.   DOI
21 Streckfus C, Bigler L (2005). The use of soluble, salivary c-erbB-2 for the detection and post-operative follow-up of breast cancer in women: the results of a five-year translational research study. Adv Dent Res, 18, 17-24.   DOI
22 Streckfus C, Bigler L, Dellinger T, et al (1999). CA 15-3 and c-erbB-2 presence in the saliva of women. Clin Oral Investig, 3, 138-43.   DOI   ScienceOn
23 Xiaoqiang Tang (2013). Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer. Cancer Lett, 332, 3-10.   DOI   ScienceOn
24 Tarhan M-O, Gonel A, Kucukzeybek Y, et al (2013). Prognostic significance of circulating tumor cells and serum ca15-3 levels in metastatic breast cancer, single center experience, preliminary results. Asian Pac J Cancer Prev, 14, 1725-9.   과학기술학회마을   DOI   ScienceOn
25 Tjemslanda L, Soreide JA (2004). Operable breast cancer patients with diagnostic delay oncological and emotional characteristics. Eur J Surg Oncol, 30, 721-7.   DOI
26 Toth B, Nieuwland R, Liebhardt S, et al (2008). Circulating microparticles in breast cancer patients: a comparative analysis with established biomarkers. Anticancer Res, 28, 1107-12.
27 Zhang S-J, Hu Y, Qian H-L, et al (2013). Expression and significance of ER, PR, VEGF, CA15-3, CA125 and CEA in judging the prognosis of breast cancer. Asian Pac J Cancer Prev, 14, 3937-40.   과학기술학회마을   DOI   ScienceOn